Shanghai Universal Biotech Co.,Ltd.

SZSE:301166 Rapporto sulle azioni

Cap. di mercato: CN¥2.6b

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Shanghai Universal BiotechLtd Salute del bilancio

Salute finanziaria criteri di controllo 6/6

Shanghai Universal BiotechLtd has a total shareholder equity of CN¥2.1B and total debt of CN¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CN¥2.4B and CN¥242.3M respectively.

Informazioni chiave

0%

Rapporto debito/patrimonio netto

CN¥0

Debito

Indice di copertura degli interessin/a
ContantiCN¥1.41b
Patrimonio nettoCN¥2.12b
Totale passivitàCN¥242.28m
Totale attivitàCN¥2.36b

Aggiornamenti recenti sulla salute finanziaria

Nessun aggiornamento

Recent updates

What Shanghai Universal Biotech Co.,Ltd.'s (SZSE:301166) 25% Share Price Gain Is Not Telling You

May 08
What Shanghai Universal Biotech Co.,Ltd.'s (SZSE:301166) 25% Share Price Gain Is Not Telling You

Shanghai Universal BiotechLtd's (SZSE:301166) Sluggish Earnings Might Be Just The Beginning Of Its Problems

May 03
Shanghai Universal BiotechLtd's (SZSE:301166) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Analisi della posizione finanziaria

Passività a breve termine: 301166's short term assets (CN¥2.0B) exceed its short term liabilities (CN¥210.4M).

Passività a lungo termine: 301166's short term assets (CN¥2.0B) exceed its long term liabilities (CN¥31.9M).


Storia e analisi del rapporto debito/patrimonio netto

Livello di debito: 301166 is debt free.

Riduzione del debito: 301166 has no debt compared to 5 years ago when its debt to equity ratio was 9.7%.

Copertura del debito: 301166 has no debt, therefore it does not need to be covered by operating cash flow.

Copertura degli interessi: 301166 has no debt, therefore coverage of interest payments is not a concern.


Bilancio


Scoprire le aziende sane